TWA
KYMR icon

TCI Wealth Advisors’s Kymera Therapeutics KYMR Stock Holding History

TCI Wealth Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-236
Closed -$6.99K – 1284
2023
Q1 		$6.99K Hold
236
– – ﹤0.01% 1303
2022
Q4 		$5.89K Hold
236
– – ﹤0.01% 1414
2022
Q3 		$5K Hold
236
– – ﹤0.01% 1476
2022
Q2 		$5K Buy
+236
New +$5.51K ﹤0.01% 1501
2022
Q1 		– Sell
-90
Closed -$6K – 2341
2021
Q4 		$6K Buy
90
+29
+48% +$1.69K ﹤0.01% 1545
2021
Q3 		$4K Buy
61
+15
+33% +$870 ﹤0.01% 1771
2021
Q2 		$2K Buy
+46
New +$2K ﹤0.01% 2036

Other funds holding KYMR

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return